Roberts Eiry's Form 4 filing
Neurocrine Biosciences Inc (NBIX) · filed Feb 8, 2024
- Accession no.
- 0000914475-24-000049
- Filed
- Feb 8, 2024
- Trade date
- Feb 6-8, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $291.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Roberts EiryCIK 0001727606 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 6, 2024 | Common Stock | SSaleDisposed | −1,121 | $142.24 | −$159,451.04 | 21,837 | Direct | |
| Feb 8, 2024 | Common Stock | SSaleDisposed | −980 | $134.21 | −$131,525.8 | 22,717 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.